HDAC6 and Parkinson disease: In animal experimental models of PD and Huntington’s diseases, HDAC6 inhibition rescues axonal transport defects and is beneficial for the neuronal survival (Dompierre et al., 2007; Godena et al., 2014; Pinho et al., 2016; Jian et al., 2017).